GeneDx Holdings WGS EPS (Diluted)
Discontinued — last reported Q1 '26
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about GeneDx Holdings's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GeneDx Holdings's EPS (diluted)?
- GeneDx Holdings (WGS) reported EPS (diluted) of -$2.16 in Q1 2026.
- How has GeneDx Holdings's EPS (diluted) changed year-over-year?
- GeneDx Holdings's EPS (diluted) decreased by 839.1% year-over-year, from -$0.23 to -$2.16.
- What is the long-term trend for GeneDx Holdings's EPS (diluted)?
- Over 2 years (2022 to 2025), GeneDx Holdings's EPS (diluted) has grown at a -88.3% compound annual growth rate (CAGR), from -$54.45 to -$0.75.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.